Common variance! [Design Issues]

posted by ElMaestro  – Denmark, 2012-06-11 22:34 (4758 d 19:53 ago) – Posting: # 8688
Views: 10,076

Hi Jag009,

❝ I thought about adaptive design as well but then timing would become an issue since bioanalytical would be involved during the process? The stupid thing is we want to test all and hit the spot with one (hopefully). It is a resource (outsourcing) vs time issue.


And on a side note I have to say I think this is becoming almost a syndrome now in the pharma industry. Everything is being LEAN'ed into dysfunctionality where management dictates a "yes we can"-attitude which is basically founded in hot air. Another syndrome is the "fight for it"-order that top management issues when studies have gone so pearshaped that noone (except management) believes it can be accepted by the regulatory authority.
Now I've said it. It feels good. I will now take my medicine. Sorry. Back into my cage.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
46 visitors (0 registered, 46 guests [including 11 identified bots]).
Forum time: 18:28 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5